HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Procter & Gamble

This article was originally published in The Rose Sheet

Executive Summary

Bids for Biactol and Topexan European skin care brands solicited as P&G considers whether to divest the lines, the company announces Jan. 10. The intended sale will allow P&G to focus on its leading global brands such as Clearasil and Oil of Olay, the firm says. Biactol and Topexan are sold in France and Italy, respectively. Although the brands represented less than 1% of P&G's total global beauty care sales in fiscal years 1998 and 1999, they are profitable and are considered leaders in their respective segments
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS007567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel